RecruitingNot Applicable

Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery

United States1,032 participantsStarted 2025-09-22

Plain-language summary

The purpose of this study is to assess the effect of quantitative block monitoring versus less expensive qualitative monitoring treatment effects on the lowest SpO2/FiO2 ratio in the PACU. The results will be incorporated into an enhanced recovery pathway for surgical patients.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patient age ≥ 18 years old; * General anesthesia with endotracheal intubation; * Neuromuscular block with rocuronium. Exclusion criteria: * Intubation before induction of anesthesia; * Critically ill patients admitted from the ICU; * Emergency cases; * Non-intubated patients; * Patients who will not be paralyzed through the surgery (spine). * Patients with an implanted electronic device (e.g. cardiac pacemaker) * Patients with allergies to adhesive * Patients with pre-existing neuromuscular disease (e.g. Myasthenia Gravis)

What they're measuring

lowest SpO2/FiO2 ratio in the PACU (constant for at least 10 minutes)

Timeframe: During the time in PACU (about 30 minutes to 6 hours)

Trial details

NCT IDNCT07084363

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-15

Contact for this trial

Mehmet Turan, MD

(713) 500-6251 Mehmet.A.Turan@uth.tmc.edu

View on ClinicalTrials.gov More Neuromuscular Block, Residual trials